NBIO Hisse Senedi Fiyat Grafiği
NBIO Kazanmak
Nascent Biotech Inc
$0
0%
$0
Kapanışta: May 07, 16:00:00 GMT-4
$0
0%
$0
Sonrası Piyasa: May 07, 20:00:00 GMT-4
Geri
Nascent Biotech Inc (NBIO) Kazanmak
Önemli İstatistikler
Önceki Kapanış
$0.0002
Açılış fiyatı
$0.0002
Günün Aralığı
$0.0002 - $0.0005
52 haftalık aralık
$0.0001 - $0.1345
İşlem hacmi
15.0K
Ort.Hacim
52.2K
Dividend yield
--
EPS (TTM)
-0.01
Piyasa Değeri
$34.4K
NBIO nedir?
Nascent Biotech, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of monoclonal antibodies for the treatment of various forms of cancer. The company is headquartered in North Palm Beach, Florida. The company went IPO on 2012-06-06. The firm focuses on biologic drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seeks to further develop those drug candidates for commercial use. The firm's lead candidate, Pritumumab (PTB), is a human monoclonal antibody (Mab) that has progressed to Phase 2 clinical trials for the treatment of Brain Cancer. Pritumumab is a fully natural human IgG antibody that was derived using proprietary technology from a B-cell isolated from a tumor draining lymph node of a patient with cervical cancer. Its other products include CLNH5 and MultiPharm. MultiPharm is a proprietary platform technology that may have additive and synergistic effects not only for cancer therapy but also for diabetes, autoimmunity, and transplantation.
